Fem Therapeutics received the Canadian Pitch Monitor at MedCity INVEST this week after it was once appreciated by way of the target audience over 3 different well being tech and medtech startups.
Fem Therapeutics is a Montreal-based clinical instrument corporate fascinated by girls’s well being. It develops gadgets for the pelvic flooring, which will exchange with being pregnant and age, consistent with its pitch deck. Inara Lalani, co-founder and CEO, offered the industry.
“Our imaginative and prescient is to give you the Invisalign fashion in gynecology by way of developing the primary ever platform for customized gadgets for commonplace pelvic flooring stipulations,” consistent with the startup’s pitch deck. “Beginning with the most important marketplace in pelvic flooring problems the place over 1.3 billion girls are impacted, we intend to offer answers throughout a number of verticals in gynecology to assist girls age with dignity and charm.“
A part of the ache level it seeks to deal with is to expand custom designed gadgets such pessaries, menstrual cups and vaginal dilators for girls. It advanced a 3-D printing platform for custom designed pelvic well being gadgets. Pelvic flooring measurements are received the usage of a Pelvic Organ Prolapse Quantification machine and the FemTherapeutics measuring glove.
Up to now Fem Therapeutics has raised $2.5 million from buyers to improve instrument construction efforts. Fen Therapeutics seeks to boost an extra $4 million for 510(okay) clearance from the FDA, production amenities, a pivotal medical learn about and strategic gross sales.
David Kereiakes, a managing spouse with Windham Challenge Companions who additionally emceed the Canadian pitch consultation, seen in an electronic mail: “Fem Therapeutics cutting edge, efficient answers personalize healthcare for girls so sufferers can get the remedies they deserve. It’s thrilling to peer CEO Inara Lalani’s imaginative and prescient evolving girls’s well being and pushing the business additional.”
3 different corporations took section within the pitch consultation as neatly.
Achieve Orthopaedics specializes in shoulder ache from large irreparable rotator cuff tears. It objectives the phase of this affected person inhabitants who’re injured because of trauma or degradation who revel in delicate to reasonable gleno-humeral osteoarthritis who don’t seem to be applicants for different surgical interventions, consistent with its pitch deck.
A shoulder implant beneath construction by way of Achieve Orthopaedics may provide long-term advantages for this affected person inhabitants by way of serving to them be extra lively. The instrument industry is lately elevating $3 million to improve production, a medical feasibility learn about, and operations.
PragmaClin Analysis advanced a medical resolution improve software that gives real-time movement seize and checks for other folks with Parkinson’s illness. It was once co-founded by way of COO Gord Genge, who additionally has the illness, in addition to CEO Bronwyn Bridges, who has a PhD in Parkinson’s illness analysis. By way of monitoring how sufferers transfer out and in of the workplace, clinicians can expand a fuller image in their sufferers and the illness development, with an eye fixed to serving to clinicians expand extra knowledgeable and efficient steerage for sufferers.
The corporate’s regulatory pathway is device as a clinical instrument. Its device, known as PRIMS, is a affected person evaluation software for neurologists within the hospital. PRIMS is an built-in machine that displays, analyzes and charges Parkinson’s illness severity consistent with world requirements. Sufferers generate the information thru the usage of cameras and by way of filling out questionnaires and too can observe their very own growth. PragmaClin is elevating a $1.5 million seed spherical, which will probably be used to rent a U.S. medical lead in addition to a industry construction lead, whole validation paintings, download FDA clearance, and to protected a scalable production procedure, consistent with its pitch deck.
OPTT Well being’s founders are fascinated by AI to improve the giant call for for psychological well being. Its method makes use of AI and herbal language processing to investigate usual questionnaire knowledge, affected person narrative, and biomarkers to help clinicians with triage and selecting the proper care, on the proper time. The startup collects knowledge from public boards and likewise makes use of proprietary medical knowledge from 1500 sufferers, and proprietary industrial knowledge – 3,000 finish customers whose knowledge is anonymized, consistent with its pitch deck.
Right here’s how OPTT Well being’s tech works. Sufferers supply a story about why they’re searching for psychological well being care, whether or not thru a vocal or written description. OPTT’s algorithms analyze them the usage of qualitative and quantitative approaches to generate clear and devoted insights. This offers actionable insights for the care group at the affected person’s symptomatic situation/scenario classes and a care degree advice. The purpose is to offer a virtual resolution that may extra successfully diagnose sufferers and assist therapists deal with sufferers extra successfully. It has a b2b industry fashion this is in line with subscriptions, set-up charges and customization, subscription to its triage product, and care plans for far off tracking.
OPTT has raised $1 million to this point. It seeks to boost some other $1 million in bridge investment and a $2.5 million fairness spherical, basically for gross sales and advertising and marketing but additionally to improve analysis and construction, product construction, and buyer improve, consistent with its pitch deck.
Picture: Roberto Machado Noa, Getty Pictures